Infarmed defends transparency of COVID-19 vaccination process
The president of the National Authority of Medicines and Health Products (Autoridade Nacional do Medicamento e Produtos de Saúde or Infarmed) guaranteed that all COVID-19 vaccination decisions were based on clinical trial evidence. Health authorities reiterated that the process remained transparent and that no safety protocols were bypassed.
Infarmed (Autoridade Nacional do Medicamento e Produtos de Saúde) is Portugal’s national regulator for medicines and health products that approves drugs, monitors safety and enforces rules on pricing and reimbursement. In 2025 it approved 928 new medicines — 79% were generics, 38 were designated essential and 236 were national products — which affects which medicines are available and how much they cost at pharmacies.
